Buyer profile
NHS England
Get alerts when NHS England publishes a new tender — 7-day free trial, then £4.99/month.
Total contracts
1,930
Known spend
£211bn
1801 disclosed
Average value
£117m
Per contract
Active suppliers
10
Last 5 years
Top suppliers
Last 5 years- 1
University College London Hospitals NHS Foundation Trust
19 winslatest 22 Sept 2026£5bn
- 2
ACCORD-UK LTD
£2bn
- 3
Zentiva Pharma UK Ltd
17 winslatest 27 Aug 2026£2bn
- 4
Teva UK Limited
15 winslatest 27 Aug 2026£2bn
- 5
Pfizer Ltd
14 winslatest 27 Aug 2026£3bn
- 6
Imperial College Healthcare NHS Trust
13 winslatest 28 Jan 2026£5bn
- 7
Guy's and St Thomas' NHS Foundation Trust
12 winslatest 22 Sept 2026£11bn
- 8
DR REDDY'S LABORATORIES (UK) LIMITED
£1bn
- 9
Cambridge University Hospitals NHS Foundation Trust
11 winslatest 18 May 2026£5bn
- 10
Sheffield Teaching Hospitals NHS Foundation Trust
11 winslatest 22 Sept 2026£775m
What they buy
By CPV categoryHealth & social workCPV 85
320 contracts · £42bn
Medical equipment & pharmaCPV 33
163 contracts · £25bn
Business servicesCPV 79
92 contracts · £270m
IT servicesCPV 72
58 contracts · £521m
Education & trainingCPV 80
41 contracts · £42m
SoftwareCPV 48
24 contracts · £1bn
R&D servicesCPV 73
21 contracts · £9m
Architectural & engineeringCPV 71
10 contracts · £334m
Renewal radar
Awarded contracts predicted to come up for re-tender in the next 18 months
- HSCN-AWS Connectivity Service for Spine
Predicted using median duration of UK contracts in the same CPV division (11 months from contract start date → renewal expected by May 2027).
May 2027
40% confident
- LeDeR Web Platform
Predicted using median duration of past contracts from this buyer in the same CPV division (11 months from contract start date → renewal expected by Jul 2027).
Jul 2027
60% confident
- Cyber School - Off The Shelf
Predicted using median duration of UK contracts in the same CPV division (15 months from contract start date → renewal expected by Nov 2027).
Nov 2027
40% confident
Tender activity
Notices published per month — last 24 months
All contracts (1930)
Specialised - nitric oxide therapy
Nitric Oxide Therapy
Delivery of a suite of 'older people's care pathway' workshop events
NHS England are seeking expressions of interest for the below opportunity. If you are interested and able to fulfil this requirement please contact russell.greenwood@nhs.net by 12
NHS generic pharmaceuticals - wave 12
NHS National Framework Agreement for Generic Pharmaceuticals - Wave 12. Regions: Central and South West (CESW); North West and Eastern and North London (NWLN); and South East and S
NHS england integrated single financial environment
Open early engagement activity - The purpose of this market engagement is to seek market feedback in relation to a potential forthcoming procurement NHS England is holding a suppli
National framework agreement for the supply of generic pharmaceuticals - tenofovir disoproxil/emtricitabine and tenofovir disoproxil/emtricitabine/efavirenz
Invitation to offer for National Framework Agreement for the Supply of Generic Pharmaceuticals - Tenofovir Disoproxil/Emtricitabine and Tenofovir Disoproxil/Emtricitabine/Efavirenz
NHS england occupation health service
A permissible direct award from CCS Framework RM3795 for occupational health services for National Health Service Commissioning Board (NHS England) only
Home delivery service - pulmonary hypertension drugs - national - june 2022
NHS National framework for home delivery service of pulomary hypertension drugs
Home delivery service - pulmonary hypertension drugs - june 2020
NHS National framework agreement for the Homcare delivery service of licensed products for use in England and Wales for the treatment of bleeding disorders including recombinants a
International recruitment of gps - london mini-competition
International Recruitment of GPs - London Mini-Competition
NHS national generic pharmaceuticals - imatinib and valganciclovir
Invitation to offer for NHS National Generic Pharmaceuticals - Imatinib and Valganciclovir Offer reference number: CM/PHG/18/5573 Period of framework agreement: The total maximum d
NHS framework agreement for the supply of recombinant factor IX products for the treatment of haemophilia B
NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B. The framework will commence on 1st March 2019 for a period of
NHS framework agreement-homecare treatment of lysosomal storage disorders
NHS National Framework Agreement Home Delivery Service Lysosomal Storage Disorders for 2 years with option(s) to extend for up to 24 months.
NHS framework agreement for branded medicines - north of england - tranche A
NHS Framework for North of England, Branded Medicines - Tranche A CM/PHR/16/5526/01- 1 March 2019 to 28 February 2021 (Option to extend for up to 24 months) CM/PHR/16/5526/02- 1 Ma
Specialised - recombinant factor IX
Recombinant Factor IX
RTL084 independent mental health advocacy (IMHA) services at broadmoor hospital
NHS England (hereafter referred to as ''The Authority'') invites completed Invitation to Tender (ITT) submissions from all suitable providers to deliver the independent advocacy se
NHS england - midlands and east branded medicines - tranche B
NHS Framework for the Midlands and East, Branded Medicines - Tranche B, Offer reference number: CM/PHR/16/5524 Period of framework agreement: CM/PHR/16/5524/01 - NHS Framework for
NHS pharmaceutical products transition 2018_2
NHS National Framework Agreement for Pharmaceuticals - Transition 2018_2. Regions: Central and South West (CESW); North West and Eastern and North London (NWLN); and South East and
Sexual violence grants programme - notice
NHS England (London) is seeking applications from voluntary organisations for projects or services that support survivors of sexual violence in London and improve survivors' experi
NHS national framework agreement for the supply of adalimumab
for NHS National Framework Agreement for Adalimumab Injection, Framework Period: 1 December 2018 - 30 November 2019 with an option to extend (at the Authority's discretion) for a p
Supply participating trusts with endocuff vision® devices - contract award
Contract award notice relating to a service exempt under Regulation 14 of PCR 2015